Empagliflozin Treatment in HFrEF With Comorbid Diabetes/Prediabetes
Patients with HFrEF who were diabetic or prediabetic had reduced left ventricular volumes following therapy with empagliflozin.
All articles by Jessica Nye, PhD
Ring-Like LV Scar Associated With Malignant Arrhythmic Events in Idiopathic Nonsustained Ventricular Arrhythmias
Ring-like nonischemic left ventricular scarring in patients with idiopathic nonsustained ventricular arrhythmias may be associated with malignant arrhythmic events.
Risk for Complications in Patients Hospitalized for COVID-19 With a History of Heart Failure
Patients hospitalized with COVID-19 who have a history of heart failure were found to have greater mortality risk.
Aspirin-Free DAPT Regimen Associated With Reduced Risk for Bleeding in Patients Undergoing SPCI for ACS
A novel vs reference DAPT regimen after staged PCI was found to reduce the risk for bleeding in patients with acute coronary syndrome.
Worsening Renal Function May Be Associated With LVEF in Acute Heart Failure
Worsening renal function may be associated with left ventricular ejection fraction in patients with acute heart failure.
Patients With Diabetes and CVD on Empagliflozin Have Fewer CV, Renal Events
Researchers assessed the risk for obstructive sleep apnea (OSA) among patients with type 2 diabetes and cardiovascular disease taking empagliflozin and further examined the effect of OSA on metabolic, cardiovascular, and renal outcomes.
Efficacy of Endothelin Receptor Antagonists for Renal Protection in Diabetic Kidney Disease
Atrasentan outperformed both avosentan and bosentan for renoprotection in patients with type 2 diabetic kidney disease.
Gout May Not Be Associated With Cardiovascular Complications in Peripheral Artery Disease
Gout was not found to be associated with increased risk for cardiovascular complications in patients with peripheral artery disease.
SARS-CoV-2 Detected in the Myocardium of Patients Who Died From COVID-19
SARS-CoV-2 was detected in the myocardium of patients who had died from COVID-19.
Risk for Bradycardia in Patients With COVID-19 Treated With Ritonavir
Ritonavir may increase the risk for bradycardia among critically ill patients with COVID-19.
-
Loading...
-
Loading...
Next post in Cardiovascular Disease (CVD)
